- Enzymes
- Recombinant
Recombinant
-
Recombinant (643)
N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential general biomarker for multiple malignancies (such as lung cancer, breast cancer, head and neck cancer, etc.). N-Acetylgalactosamine-6-Sulfatase deficiency causes mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. N-Acetylgalactosamine-6-Sulfatase can be used in MPS IVA as well as cancer research.
August 31
-
Please select quantity
August 31
Obtenir un devis
Lysosomal α-Glucosidase (EC:3.2.1.20) is a lysosomal α-Glucosidase that degrades glycogen into glucose and catalyzes the hydrolysis of α-1,4 and α-1,6 glycosidic linkages in glycogen, as well as that of natural and synthetic oligoglucosides. Deficiency of Lysosomal α-Glucosidase causes type II glycogen storage disease (Pompe disease), which is characterized by lysosomal glycogen accumulation in mammals and birds. Lysosomal α-Glucosidase can be used in research related to type II glycogen storage disease.
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
β-1,3-N-Acetylglucosaminyltransferase 4 (EC:2.4.1.149, B3GNT4) is involved in the synthesis of poly-N-acetyllactosamine and has activity for type 2 oligosaccharides.
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 ( EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II) is a glycosyltransferase .
August 31
-
Please select quantity
August 31
Obtenir un devis
ST6 Sialyltransferase 4 (EC:2.4.3.7; ST6GALNAC4; SIAT3-C; SIAT3C; SIAT7-D; SIAT7D) catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. ST6 Sialyltransferase 4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation..
August 31
-
Please select quantity
August 31
Obtenir un devis
ST6 Sialyltransferase 2 (EC:2.4.3.3, ST6GALNAC2) add sialic acids to the nonreducing ends of glycoconjugates.
August 31
-
Please select quantity
August 31
Obtenir un devis
ST6 Sialyltransferase 1 (EC:2.4.3.3, ST6GALNAC1, SIAT7A, Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1) transfers a sialic acid, N-acetylneuraminic acid (NeuAc), in an alpha-2,6 linkage to O-linked GalNAc residues. ST6 Sialyltransferase 1 plays an important role in cancer.
August 31
-
Please select quantity
August 31
Obtenir un devis
ST6 Gal Sialyltransferase 2 (EC:2.4.3.1, ST6GAL2) catalyzes the transfer of sialic acid from CMP to an oligosaccharide substrate. ST6 Gal Sialyltransferase 2 plays an important role in schizophrenic research.
August 31
-
Please select quantity
August 31
Obtenir un devis
ST3 beta-Gal alpha-2,3-Sialyltransferase 6 (EC:2.4.99., ST3GAL6; SIAT10, Type 2 lactosamine alpha-2,3-sialyltransferase) transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. ST3 beta-Gal alpha-2,3-Sialyltransferase 6 play an important role in cancer.
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis